TM RVS BASE PLT 25MM POST +2
Report
- Report Number
- 0001822565-2025-04316
- Event Type
- Injury
- Date Received
- November 25, 2025
- Date of Event
- September 22, 2022
- Report Date
- April 8, 2026
- Manufacturer
- ZIMMER BIOMET, INC.
- Product Code
- PHX
- UDI-DI
- 00889024269033
- PMA / PMN Number
- K130661
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
(B)(4). MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT. ASSOCIATED REPORTS ARE AVAILABLE FOR THE APPLICABLE CONCOMITANT PRODUCTS BELOW IN THE D10 NARRATIVE. D10: CONCOMITANT MEDICAL PRODUCTS, PART (LOT): -00434902502(63255091). D10: ASSOCIATED PRODUCT INFORMATION, PART (LOT): -211216(527760) - 211239(357120) - 115370(347800) - EP-115394(213470) -211228(262520) -211228(262540). THE CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION AS IT REMAINS IMPLANTED. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. IF ANY FURTHER INFORMATION IS FOUND THAT WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.
IT WAS REPORTED THAT DURING A CLINICAL STUDY A PATIENT HAD AN INITIAL RIGHT REVERSE TOTAL SHOULDER ARTHROPLASTY. APPROXIMATELY 15 DAYS POST-IMPLANTATION, THE PATIENT COMPLAINED OF PAIN AND RECEIVED A STEROID INJECTION INTO THE DELTOID MUSCLE. POSTERIORLY, APPROXIMATELY 5 YEARS LATER, PERSISTENT PAIN WAS REPORTED WITH NO TREATMENT. FINALLY, APPROXIMATELY 5 YEARS POST-IMPLANTATION, THE STUDY WAS COMPLETE WITH ALL COMPONENTS REMAINING IMPLANTED. IT WAS REPORTED THAT NO FURTHER INFORMATION IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 431426 | TM RVS BASE PLT 25MM POST +2 | SHOULDER PROSTHESIS, REVERSE CONFIGURATION | PHX | ZIMMER BIOMET, INC. | 63255091 | 00889024269033 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR | Female | Other | SEE H11 |